ebook Munafa Stock Market Course + Intraday & FNO calls  

       

REGN announcements Regeneron Pharmaceuticals, Inc. announcements and dividends declared NASDAQ

Regeneron Pharmaceuticals, Inc. Complete list of announcements declared & dividend announcements by Regeneron Pharmaceuticals, Inc. REGN

Regeneron Pharmaceuticals, Inc. REGN listed on NASDAQ and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Regeneron Pharmaceuticals, Inc. REGN

Cantor Fitzgerald Reiterates Regeneron Pharmaceuticals (REGN) Neutral Recommendation
Fintel reports that on September 21, 2023, Cantor Fitzgerald reiterated coverage of Regeneron Pharmaceuticals (NASDAQ:REGN) with a Neutral recommendation.
Announcement as on 22 September 2023

Truist Securities Reiterates Regeneron Pharmaceuticals (REGN) Buy Recommendation
Fintel reports that on August 16, 2023, Truist Securities reiterated coverage of Regeneron Pharmaceuticals (NASDAQ:REGN) with a Buy recommendation.
Announcement as on 16 August 2023

Regeneron Pharmaceuticals Q3 tops earnings and revenue marks
Regeneron Pharmaceuticals Inc. said Thursday its third-quarter net income fell 19% to .32 billion or .66 a share, from .63 billion or .33 a share, in the year-ago period. Adjusted net income fell to .14 a share from .37 a share. Revenue at
Announcement as on 03 November 2022

Regeneron Pharmaceuticals Reaches Analyst Target Price
In recent trading, shares of Regeneron Pharmaceuticals, Inc. (Symbol: REGN) have crossed above the average analyst 12-month target price of 6.45, changing hands for 0.88/share. When a stock reaches the target an analyst has set, the analyst logicall
Announcement as on 26 May 2022

Regeneron Pharmaceuticals Reaches Analyst Target Price
In recent trading, shares of Regeneron Pharmaceuticals, Inc. (Symbol: REGN) have crossed above the average analyst 12-month target price of 9.33, changing hands for 3.27/share. When a stock reaches the target an analyst has set, the analyst logicall
Announcement as on 23 August 2021

Announcements by Regeneron Pharmaceuticals, Inc. first page | Next page | Prev page |

REGN Regeneron Pharmaceuticals, Inc. current price & indicator signals

Moving Averages for Regeneron Pharmaceuticals, Inc.

  • 5Day Average: 758.44
  • 12Day Average: 739.42
  • 20Day Average: 746.26
  • 50Day Average: 682.52
  • 100Day Average: 628.13
  • 150Day Average: 599.92
  • 200Day Average: 601.25

REGN Indicators & signals

Indicator MACD (12,26,9)

748.93, 729.11, 19.7
Indicator MACD is in positive zone

Indicator ADX (14)

30.94, 33.89, 17.87
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 63
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of REGN Regeneron Pharmaceuticals, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
22 Mon Dec 2025 779.36 765.09 to 783.60 1.48% 0.77 times
19 Fri Dec 2025 767.96 748.18 to 773.85 2.57% 2.18 times
18 Thu Dec 2025 748.71 739.23 to 752.84 -0.14% 0.99 times
17 Wed Dec 2025 749.79 743.33 to 751.99 0.46% 0.72 times
16 Tue Dec 2025 746.36 734.72 to 757.35 -0.83% 0.67 times
15 Mon Dec 2025 752.62 746.38 to 756.67 1.53% 0.87 times
12 Fri Dec 2025 741.29 734.38 to 746.05 -0.74% 0.75 times
11 Thu Dec 2025 746.80 726.08 to 753.61 2.84% 1.08 times
10 Wed Dec 2025 726.21 692.50 to 728.00 4.86% 1.23 times
09 Tue Dec 2025 692.58 691.86 to 711.15 -1.52% 0.57 times
08 Mon Dec 2025 703.26 701.74 to 724.13 -2.06% 0.94 times
05 Fri Dec 2025 718.05 717.26 to 736.15 -0.66% 0.34 times

Videos related to: REGN announcements Regeneron Pharmaceuticals, Inc. announcements and dividends declared NASDAQ

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

REGN announcements Regeneron Pharmaceuticals, Inc. announcements and dividends declared NASDAQ

 

Back to top